Evolving Personalized Therapy for Castration-Resistant Prostate Cancer

With advances in molecular biologic and genomic technology, detailed molecular mechanisms for development of castration-resistant prostate cancer (CRPC) have surfaced. Metastatic prostate cancer (PCa) no longer represents an end stage, with many emerging therapeutic agents approved as effective in p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biomedicine (Taipei)
Hlavní autoři: Liu, Hsin-Ho, Tsai, Yuh-Shyan, Lai, Chen-Li, Tang, Chih-Hsin, Lai, Chih-Ho, Wu, Hsi-Chin, Hsieh, Jer-Tsong, Yang, Che-Rei
Médium: Artigo
Jazyk:Inglês
Vydáno: China Medical University 2014
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4264971/
https://ncbi.nlm.nih.gov/pubmed/25520915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7603/s40681-014-0002-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky